Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

476
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
476
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.2K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.2K
Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

894
Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased...
894
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

577
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
577
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sources and transmission dynamics of Campylobacter and Shigella using culture-independent molecular methods in Tanzania (SCAT): a protocol for a prospective observational cohort study.

medRxiv : the preprint server for health sciences·2026
Same author

The consequences of <i>Shigella</i> medically-attended diarrhoea and other leading pathogens among young children living in high-burden settings: a multi-country prospective cohort study.

EClinicalMedicine·2026
Same author

Human-milk vitamin B-3 (niacin and vitamer) concentrations: secondary analysis of a randomized, placebo-controlled trial of maternal nicotinamide supplementation in rural Tanzania.

The American journal of clinical nutrition·2026
Same author

Kinetics of Enteric Pathogen Quantity During Acute Diarrhea in Children in Resource-Limited Settings.

Open forum infectious diseases·2026
Same author

Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study.

PLoS neglected tropical diseases·2026
Same author

Impact of Azithromycin Administration at Hospital Discharge on Antimicrobial Resistance and Enteropathogen Carriage 3 Months Following Treatment.

medRxiv : the preprint server for health sciences·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: Feb 16, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

1.5K

Shigellosis.

Karen L Kotloff1, Mark S Riddle2, James A Platts-Mills3

  • 1Departments of Pediatrics and Medicine, Center for Vaccine Development, Institute for Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Lancet (London, England)
|December 20, 2017
PubMed
Summary
This summary is machine-generated.

Shigellosis, a severe diarrheal disease, causes significant global mortality, especially in young children. Emerging antibiotic resistance necessitates new treatments and vaccine development to combat this infectious threat.

More Related Videos

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions
12:52

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions

Published on: September 9, 2014

16.4K
A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

12.5K

Related Experiment Videos

Last Updated: Feb 16, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

1.5K
Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions
12:52

Use of Shigella flexneri to Study Autophagy-Cytoskeleton Interactions

Published on: September 9, 2014

16.4K
A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

12.5K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Shigellosis is a severe intestinal infection caused by Shigella species.
  • It disproportionately affects young children in low-income settings, causing substantial disease burden.
  • Manifestations range from diarrhea to severe dysentery with potential complications.

Purpose of the Study:

  • To summarize the global burden of shigellosis.
  • To highlight emerging threats like antimicrobial resistance.
  • To discuss the need for new interventions, including vaccines.

Main Methods:

  • Literature review and synthesis of epidemiological data.
  • Analysis of clinical manifestations and complications.
  • Review of current treatment recommendations and vaccine development status.

Main Results:

  • Shigellosis causes an estimated 164,000 annual deaths globally.
  • Multidrug-resistant Shigella strains are spreading internationally.
  • Several Shigella vaccine candidates are in clinical trials.

Conclusions:

  • Shigellosis remains a major global health concern, particularly in vulnerable populations.
  • Antimicrobial resistance poses a significant challenge to treatment.
  • Vaccine development is crucial for controlling shigellosis transmission and reducing mortality.